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The effects of  oligoribonucleotides of identical or similar sequences to a 
ribosomal protein binding site, specifically S8, on prokaryotic 30S ribosomal assembly 
were investigated in Escherichia coli. The oligoribonucleotides were expected to bind to 
the target protein S8 and block its incorporation into the 30S subunit, resulting in a non-
functional particle. 30S assembly has been proposed to occur by similar pathways both in 
vivo and in vitro.  If this block in assembly by the oligoribonucleotides occurs in vitro, it 
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The binding site of  S8 was delivered into E.  coli through a phagemid delivery 
system.  The S8 binding site was cloned into a PBS+ vector under control of  a lacZ 
promoter.  The same phagemid with the ribosomal binding site of  the lacZ gene deleted 
(the Shine-Dalgarno sequence and translational start site deleted) was also cloned and 
both transformed into E.  coli.  Growth experiments were performed in the presence and 
absence of  the inducer isopropylthiogalactoside (lPTG).  No change in growth upon 
induction of  the phagemids was observed.  Northern blot analysis was performed on cell 
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with the deleted ribosomal binding site produced no message corresponding to either the 
S8 binding site or lacZ mRNA, possibly due to endonucleolytic attack upon the message. 
Omission of  protein S8 in an in vitro reconstitution reaction results in subunits 
that show an 87-98 % reduction in phenylalanine incorporation in the polyphenylalanine 
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Chapter 1 
Introduction 
1.1  Statement of Problem 
Bacteria exist almost everywhere and make up a large proportion of  the biomass of 
this planet.  Most bacteria cause little or no harm and some are useful to humans by 
inhibiting harmful bacteria.  Some bacteria, though, are capable of  causing disease in 
humans and some beneficial bacteria can be harmful depending on the location of  the 
bacteria on or in the host. 
Antibacterial agents are anything that can kill or inhibit the growth of  bacteria. 
Antibacterial drugs, or antibiotics, are used in low concentrations in or on an organism to 
treat bacterial disease with little or no harm to the host organism.  Antibiotics are also 
used as growth enhancers in production feed animals.  Resistance to antibiotics is a 
phenomenon that enables some bacteria to survive the effects of  antibiotics. 
Antibiotic resistance is a major problem nationally and worldwide but data are 
insufficient to determine the full extent of  the public health burden (Health, Education 
and Human Services, 1999).  Antibiotic resistance has shown up in major pathogenic 
organisms including Staphylococcus aureus, Mycobacterium tuberculosis, Neisseria 
gonorhoeae, enteric pathogens, and many others (Neu, 1992).  In 1997, a report was 
released on a 1995 clinical case of  multidrug-resistant Yersinia pestis, the organism responsible for bubonic plague and a species previously considered universally 
susceptible to antibiotics (Galimand et aI.,  1997). 
Resistance to antibiotics occurs through four major mechanisms.  One is the 
destruction or modification of  the antibiotic that renders the antibiotic inactive. 
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Examples of  this mechanism are J3-lactamase and aminoglycoside modifying enzymes 
(Shaw et aI.,  1993).  Another mechanism of  resistance is effiux of  the antibiotic.  An 
example is the tetracycline transport protein Tet A (Allard and Bertrand, 1993).  Another 
mechanism prevents access of  the antibiotic to the target due to an alteration of  cell 
permeability to the antimicrobial agent as is sometimes the case with the quinolones 
(Dechene et aI., 1990; Poole et aI., 1993) and with the J3-lactams (Chou et aI., 1993). 
Sometimes the resistance can take the form of  alteration of  the antibiotic target site. 
Resistance to the macrolide class of  antibiotic is usually caused by a methylase that 
methylates an adenine residue in the peptidyl transferase domain of  the 23S RNA 
(Ballow and Amsden, 1992).  Resistance to vancomycin involves the action of nine genes 
that act overall to alter the peptidoglycan layer of  the cell wall causing the drug to have a 
lower affinity for its target (Walsh, 1993). 
The cost of  resistance has been difficult to assess due to lack of  a complete national 
surveillance system on infectious disease and resistant infections.  Sources provide data 
on only part of  the burden and some are based on models (Phelps, 1989).  Estimates vary 
widely depending on whether the studies take factors into account such as indirect costs, 
impatient vs.  outpatient costs, social costs, and the cost of  premature deaths.  For 
instance, Cohen (1992) reported that the estimated cost for treating a tuberculosis (TB) 
case increases from $12,000 for a susceptible strain to $180,000 for a drug-resistant 3 
strain.  But in 1995, Brown (Brown et aI., 1995) reported that in 1991, the cost was 
$2,300 for susceptible and $8,000 for drug-resistant TB.  Brown reported only 
expenditures for outpatient TB by patient type.  Therefore, an increase of  three to over 
tenfold can be assumed for drug-susceptible vs.  drug-resistant strains of  bacteria. 
According to a 1997 survey (Health, Education and Human Services, 1999) the number 
of  hospital discharges of  patients diagnosed with and treated for infections from drug-
resistant bacteria increased from 11,000 in 1994 to 43,000 in 1997.  Data on deaths due to 
resistant bacteria are not available because resistance does not get reported on death 
certificates. 
Public health strategies to address antimicrobial resistance include improved 
surveillance, at the national and international level (for an inventory of  global 
surveillance systems on infectious disease see Harrison and Lederberg, 1998), rational 
use of  antimicrobial drugs in both human and animal medicine as well as more prudent 
use of  antibiotics in food production, control and guidelines to reduce the spread of 
infection and antibiotic resistance within the hospital and health care settings.  Basic 
research is needed on the mechanisms of  antibiotic resistance and research on rapid and 
reliable diagnostic tests and on vaccines.  Another important strategy is research and 
development into new antimicrobial compounds (American Society for Microbiology 
Task Force, 1994). 
Antibiotics currently on the market attack a relatively small number of  targets (for 
review see Williams et aI., 1996).  Keeping ahead of  antibacterial resistance will require 
expanding the number of  antimicrobials with novel targets and drug actions.  Genomic 
research is already underway to probe bacterial genomes for new targets.  Gene sequencing allows for tremendous comprehension into how organisms alter themselves, 
biochemical pathways and transport mechanisms associated with virulence, resistance, 
and infectivity.  Gene arrays, that allow for simultaneous study of  all genes within a 
genome, can allow for research under different physiological conditions and the study of 
variations in virulence and infectivity as well as identification and study of  genes 
associated with antimicrobial resistance (Ventor, 1998). 
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In March of2000, at least two new drugs were awaiting approval from the Food and 
Drug Administration (FDA) (Henry, 2000).  One is a completely new class of  antibiotics, 
the oxazolidinones from Pharmacia and Upjohn.  The oxazolidinones are five-membered 
heterocyclic ring structures that appear to act by binding the small ribosomal subunit and 
preventing the interaction during initiation of  the small subunit, messenger RNA 
(mRNA), and formyl methionine.  Linezolid, the first member of  this class, is active 
against gram-positive bacteria.  Another antibiotic waiting for FDA approval is 
gemifloxacin, a next-generation fluoroquinolone.  Fluoroquinolones inhibit type II 
topoisomerase.  Other antimicrobial drugs are under development but new classes are 
few. 
1.2  Thesis Topic 
The ribosome is the platform upon which protein synthesis occurs.  The prokaryotic 
ribosome is a large macromolecular complex made up of  both RNA and proteins, which 
sediments at 70S.  It has two subunits, the 50S and 30S, named for their sedimentation 
coefficients.  The 30S subunit has one RNA molecule, the 16S RNA.  In E.  coli the 16S 
RNA is  1542 bases long.  Complexed to the 16S RNA, the 30S subunit has 21  proteins, 
designated S-proteins. 5 
30S subunits can be reconstituted in vitro from purified 16S RNA and purified 30S 
proteins (TP30) (Traub and Nomura, 1969).  These particles are found to be almost 
identical to isolated, non-reconstituted 30S particles with respect to sedimentation profile, 
protein composition, and functionality.  Overall 30S reconstitution is stepwise, first order, 
and proceeds via the formula:  16S RNA + TP30 ~  RI (heatlMg++) ~  RI* ~  30S.  The 
RI particle (reconstitution intermediate) undergoes a conformational, unimolecular 
rearrangement to the activated RI particle (RI*), and this rearrangement is the rate 
limiting step.  Thirteen proteins (S4, S6, S7, S8, S9, SII, S13, SIS, S16, S17, SI8, SI9, 
and S20) and the 16S RNA make up the RI particle (Nomura et ai., 1969; Bryant et ai., 
1974).  Of  these thirteen proteins, S6, S  13, and S20 are found in the isolated RI particle 
but don't appear to be required for the RI ~  RI* transition (Held and Nomura, 1973). 
Proteins SS,  S12, and possibly S19 appear to bind weakly to the RI particle at low 
temperature and are not found in the isolated RI particle but are needed for the 
temperature-dependant RI ~  RI* step and fully active 30S subunits.  After the RI ~  RI* 
transition, the remaining 30S proteins can then bind the RI* and form active 30S 
subunits. 
An in vitro 30S assembly map has been developed (Mizushima and Nomura, 1970; 
Held et aI.,  1974).  Proteins that bind to the 16S RNA in the absence of  other proteins are 
called primary binding proteins.  These are proteins S4, S17, S20, S8, SIS, and S7.  Of 
these, proteins S4 and S7 initiate 30S-subunit assembly in a domain-like fashion 
(Notwotny and Nierhaus, 1988).  It has been suggested that S8 and its neighbor protein 
SS  play an important role in the interconnection of  the two assembly domains.  Proteins 
that require the binding of  the primary proteins to the 16S RNA in order for them to bind to the subunit are called secondary proteins.  For instance, protein SS binds to a short, 
double strand, imperfect helical region in domain II of  the 16S RNA between bases 590-
659 (E.  coli numbering) and is a primary protein.  Protein S5, a secondary protein, 
requires the binding of  protein SS and also S 16 in order for it to bind to the subunit. 
Protein S3 requires the binding of  protein S5 and the binding of  protein S2 is facilitated 
by the binding of  protein S3.  Omitting any of  the primary binding proteins from the 
reconstitution mixture except S20 results in subunits with diminished functionality, that 
sediment between 20S and 25S, and are deficient in some secondary proteins as well as 
the omitted primary binding protein (Nomura et al., 1969). 
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The study of  ribosome assembly in vivo has been studied primarily through cold 
sensitive mutants defective in ribosome assembly (Nashimoto et al., 1971; Bryant et al., 
1974), pulse-labeling experiments (Lindahl, 1975), and precursor particles that have been 
isolated during in vivo assembly (Nierhaus et al., 1973).  One precursor particle, P130S, 
does not have a full complement of  30S proteins.  It sediments at approximately 21 S. 
These precursor particles isolated from different labs have similar protein profiles to the 
in vitro RI particle (Held and Nomura, 1973; Nierhaus, 1991). 
The aim of  this research is to inhibit complete 30S assembly in vitro by adding an 
oligoribonucleotide identical or similar in sequence to a ribosomal protein binding site, 
specifically SS.  SS was tested because ofthe small size and simplicity of  the binding site 
on the 16S RNA.  The oligoribonucleotide binds to the target protein SS and inhibits 
protein SS's binding to the 16S RNA.  Since the targeted protein SS can no longer bind to 
the 16S RNA, some secondary proteins, namely S5, S3, and S2, also can no longer be 
incorporated into the 30S subunit resulting in a particle that sediments more slowly and is 7 
non-functional (Held et aI.,  1974; Buck et aI.,  1991).  Since 30S ribosomal subunit 
assembly has been proposed to occur by similar pathways both in vitro and in vivo, it is 
believed that if  this block in assembly occurs in vitro it would also occur in vivo if 
methods can be devised to bring about the uptake of  the inhibitory agent into bacterial 
cells.  Oligoribonuc1eotides such as these (in analog form) may serve as useful antibiotics 
that target ribosome assembly. 
1.3  Research Approach 
Oligoribonuc1eotides do not penetrate well into bacterial cells.  Therefore, to test 
whether introducing an oligoribonuc1eotide of  identical or similar sequence to the S8-
RNA binding site into the cell would block ribosomal assembly and inhibit cell growth, 
the binding site of S8 was delivered into E  coli through a phagemid delivery system. 
The S8 binding site was synthesized and inserted into a phagemid vector under control of 
a lacZ promoter by using molecular biology techniques.  The same phagemid with the 
Shine-Dalgarno and translational start site of  the lacZ gene deleted by the polymerase 
chain reaction (peR) and recircularized was also constructed and both transformed into 
E.  coli.  Spectrophotometric growth experiments were performed in the presence and 
absence of  the inducer isopropylthiogalactoside (IPTG).  In order to determine whether 
transcription occurs from the phagemid constructs, Northern blot analysis was performed 
on celllysates grown in the presence and absence of  the inducer IPTG. 
30S subunits can be reconstituted in vitro from purified 16S RNA and purified 
30S ribosomal proteins.  Omission of  protein S8 in the reconstitution reaction results in 
subunits that sediment more slowly and show an 87-98 % reduction in polyphenylalanine 
synthesis (Nomura et aI., 1969; Higo et aI.,  1973).  This severe reduction of  function was 8 
used to test the hypothesis.  Reconstitutions were performed in the presence and absence 
ofunrnodified oligoribonucleotides identical or similar in sequence to the S8 binding site 
and the reconstitution mixtures were assayed for polyU-directed polyphenylalanine 
incorporation.  Filter-binding assays were employed to test whether the 
oligoribonucleotides had a lower affinity to 30S proteins in the reconstitution than the 
16S rRNA to the 30S proteins. 
Each of  the chapters within this thesis addresses a specific topic.  Chapter 2 
reviews literature on the ribosome and ribosomal assembly, protein S8 and its binding 
site to the 16S RNA, and ribosomal component regulation. The materials and methods 
used in the investigations are discussed in Chapter 3.  Chapter 4 presents the results ofthe 
experiments performed.  Chapter 5, the final chapter, includes a discussion and analysis 
of  the results as well as clinical implications of  the experimentation. Chapter 2 
Literature Review 
2.1  The Ribosome 
Ribosomes are large ribonucleoprotein structures responsible for translation of  the 
genetic code into proteins.  The E.  coli ribosome is the most studied and is a model for 
this organelle.  The E.  coli ribosome is made up of  38 % protein and 62 % RNA.  There 
is now considerable evidence that the RNA is a functional component as opposed to just 
a structural component of  the ribosome (Green and Noller, 1997). The prokaryotic 
ribosome sediments at 70S and has two subunits, the large subunit, or 50S, and the small 
subunit, the 30S.  Recently, the 70S ribosome as well as the 50S and 30S subunits have 
been crystallized and their solutions solved to 5.5 angstroms for the 30S (Clemons et at., 
1999),5.0 angstroms for the 50S (Ban et at.,  1999), and the 70S, containing messenger 
RNA and transfer RNA, to 7.8 angstroms (Cate et at.,  1999; Culver et at.,  1999). 
Considering the amazing complexity of  the ribosome, these are amazing feats of  science 
and will prove invaluable for the study of  translation, especially when the structures are 
solved to higher resolutions. 
The 50S subunit has two RNA molecules, the 23S and the 5S.  The 5S RNA is  120 
nucleotides long in E.  coli.  The 23S RNA is 2904 nucleotides long and contains 
numerous posttranscriptional modifications including methylations and pseudouridines. 
Not all of the modifications have been placed in the sequence (Baken and Of  eng  and, 
1993).  Complexed to the RNA's are approximately 34 proteins designated Ll through 
L36.  This nomenclature is based on the proteins mobility in a two-dimensional gel 
9 electrophoresis system (Kaltschmidt and Wittman, 1970).  L8 is an aggregate of 
(L 7/L 12)4 *L 1  0, L26 is identical to protein S20, and L  7 and L 12 are identical except for 
L  7 is N-terminal acetylated. The molecular weights of  the proteins range between 4,000 
and 30,000 daltons. 
The 30S subunit has one RNA, the 16S RNA.  In E.  coli it is  1542 nucleotides long. 
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Like the 23S RNA, it too has posttranscriptional modifications including 10 methylations 
and one pseudouridine.  Through comparitive sequence analysis, it's shown to have 
extensive secondary structure and tertiary interactions including two-pseudoknot 
structures (Figure 2.1).  Complexed to the 16S RNA are 21  proteins designated S 1 to S21 
with a molecular weight range between 8,000 and 60,000 daltons.  Most ribosomal 
proteins are basic proteins with S 1, S6, and L  7  IL  12 being exceptions (Kaltschmidt, 
1971). 
The role of  the ribosome is to synthesize polypeptide chains of  specified amino acids 
that are specified by mRNA.  The ribosome has both a catalytic function and a decoding 
function.  During decoding, the tRNA is accurately aligned to the mRNA so that correct 
codon-anticodon interaction takes place.  The small subunit is the major contributor to the 
decoding site.  The peptidyl transferase region of  the ribosome catalyzes peptide bond 
formation by bringing together the aminoacyl end of  the tRNA to the peptidyl-tRNA and 
transfers the nascent polypeptide chain to the next amino acid on the aminoacyl-tRNA. 
The mRNA is moved one codon relative to the ribosome and the peptidyl-tRNA 
translocates to the P-site.  The catalytic peptidyl transferase function lies in the large 
subunit. Figure 2.1.  The primary and secondary structure of  the 16S RNA in E.  coli as deduced 
by sequence comparison analysis.  Material taken from Gutell, 1996. 
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2.2  Ribosomal Assembly 
2.2.1.  In vitro 30S Small Subunit Assembly 
30S subunits can be reconstituted in vitro from purified 16S RNA and purified 30S 
ribosomal proteins (Traub and Nomura, 1969; Held et ai., 1973).  These particles are 
found to be almost identical to isolated 30S subunits with respect to sedimentation 
profile, protein composition, and several functional abilities including tRNA binding and 
polyphenylalanine synthesis.  The reconstitution of  active ribosomes demonstrates that all 
the information needed for assembly is contained in the molecular components.  30S 
subunits have been reconstituted using heat denatured RNA (Barritault, 1979) and in 
vitro transcribed RNA (Krzyzosiak et ai., 1987), the later signifying that the base 
modifications in the 16S RNA are not absolutely required for function of  the small 
subunit. 
Functionally active hybrid 30S subunits have been reconstituted using protein and 
RNA components from different species (Nomura et ai., 1968; Higo et ai., 1973).  It was 
found that Azotobacter vinelandii and Bacillus stearothermophilus 16S RNA's can 
replace E.  coli 16S RNA in a reconstitution using E.  coli proteins.  The reconstituted 
particles had the same sedimentation profile and activity as measured by the 
polyphenylalanine synthesis assay.  The use of  Miccrococcus lysodeikticus 16S RNA in 
the reconstitution resulted in variable particles (3-36 % activity), slower sedimentation 
profile, and formed insoluble aggregates but reconstitution of  active particles using both 
16S RNA and proteins from M.  lysodeikticus was unsuccessful under the reconstitution 
conditions used as well.  The activity of  reconstituted particles using E.  coli 16S RNA 
and B.  stearothermophilus or A.  vinelandii proteins were about half the activity of  their 14 
controls (Nomura et ai., 1968).  Most individual B.  stearothermophilus proteins can 
replace Ii. coli proteins in an  ~'. coli reconstitution system.  The activity is somewhat 
variable depending on the protein.  For example, using B.  stearothermophilus S2 in the 
reaction instead of  Ii. coli S2 results in 62 % activity.  Using B.  stearothermophilus 
protein S8 instead of  E.  coli S8 results in 106 % activity.  All protein replacements except 
S2 results in 80-100 % activity compared to their controls (S 1, S6, S9, and S  13  were not 
tested) (Higo et ai., 1973).  Protein S8 from Thermus thermophilus binds the Ii. coli 
ribosomal RNA binding site as efficiently as protein S8 from E.  coli (Vysotskaya et ai., 
1994).  These results taken together suggest that the fundamental structural organization 
of  the 30S subunit is similar among eubacteria. 
Efficient reconstitution of  functional E.  coli 30S subunits has occurred using a 
complete set of  recombinant ribosomal proteins (Culver and Noller, 1999).  Interestingly, 
efficient reconstitution occurred only if  the protein components were added sequentially 
following either the 30S assembly map or following the order of  protein assembly 
predicted from in vitro assembly kinetics (both discussed below).  Reconstitution with the 
recombinant proteins was inefficient when performed by adding all of  the ribosomal 
proteins together in the mixture at the same time, which is the standard method. 
Overall reconstitution proceeds via the formula:  16S RNA + ribosomal proteins ~ 
RI (heatlMg  ++) ~  RI*  ~  30S (Traub and Nomura, 1969).  Under optimal conditions, 
ribosome assembly is sequential, cooperative, and first order with respect to active 30S 
subunits.  The RI particle (reconstitution intermediate) undergoes a conformational, 
unimolecular change to RI* (activated reconstitution intermediate) that is the rate limiting 
step to 30S particles.  When the reaction is carried out at 30°C and analyzed using 
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sedimentation centrifugation, the RI particle is isolated and sediments at 21 S.  These 
particles can then be heated (40°C) in the absence of  free protein (except protein S5, S 12, 
and S 19) and the new particles, RI*, sediment at 26S and can bind the remaining 
ribosomal proteins even at lower temperatures.  Thirteen proteins (S4, S6, S7, S8, S9, 
SII, S13, SIS, S16, S17, S18, S19, and S20) and the 16S RNA make up the isolated RI 
particle (Nomura et aI., 1969; Bryant et aI., 1974).  Some of  these proteins (S6, S9, S  13 
and S20) are found in the isolated RI particle but appear not required for the RI to RI* 
transition (Held and Nomura, 1973).  Proteins S5, S12, and S19 are not found in the 
isolated RI particle but are required for the RI to RI* transition and full activity of  the 
30S subunits, supposedly due to weak binding to the RI particle.  After the RI* transition, 
the remaining 30S ribosomal proteins are then able to bind the RI* and form fully active 
30S subunits. 
An in vitro 30S assembly map has been developed using the logic that if  a protein 
will not bind well to RNA until another protein has bound, then the first protein follows 
the second protein in the assembly reaction (Figure 2.2) (Mizushima and Nomura, 1970; 
Held et aI., 1974).  Proteins that bind to the 16S RNA in the absence of  any other proteins 
are called primary binding proteins.  These are S4, S17, S20, S8, SIS, and S7.  Of  these, 
S4 and S7 initiate 30S subunit assembly in a domain-like fashion (Nowotny and 
Nierhaus, 1988).  It has been suggested that S8 and S5 play and important role in the 
interconnection of  the two assembly domains.  Proteins that require the binding of  the 
primary proteins to the 16S RNA in order for them to bind to the particle are called 
secondary binding proteins, the remaining are called tertiary binding proteins. 
L-..-___________________________________________  .  ___ _ Figure 2.2.  Assembly map of  the 30S subunit.  Arrows between proteins show 
facilitating effect of  one protein on the binding of  another to the particle.  A thick arrow 
indicates a major facilitative effect.  The arrows from the 16S RNA to S4, S 17, S20, S8, 
SIS, and S7 indicate primary binding proteins that bind directly to the 16S RNA in the 
absence of  other proteins.  S8 and S20 (arrows not shown) as well as S9 and S19 
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facilitate the binding of S7.  S 13, S 16, S 17, S20, S8, and/or S4 may facilitate protein S  11 
but which ones are unknown.  Proteins above the solid line are those proteins found in the 
RI particle or are required for the RI to RI* transition (SS, S9, and S  12 are not found in 
the RI particle possibly due to only weak binding to the RI particle but are required for 
the RI to RI* transition).  Data taken from Held et ai, 1974. ------------~~~~--------------
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The dynamics of  in vitro assembly has also been studied using the temperature 
dependency of  the reaction (Powers et al., 1993).  Assembly complexes at different 
temperatures were chemically probed for RNA reactivity at various time points.  For 
instance, at 30°C, reconstitution takes about 2 hours to go to completion (as opposed to a 
few minutes at 40°C) and intermediate stages of  assembly can be monitored.  Some 
regions of  the RNA were protected almost immediately while others were protected at 
later stages of  assembly.  Some bases became more reactive initially and then non-
reactive later during assembly.  These experiments demonstrate that in vitro 30S 
assembly proceeds with a 5' to 3' polarity (with exception of  S5 and S 12 showing slow 
kinetics) possibly due to the coupling of  ribosome assembly to transcription. The 
experiments provided evidence for the sequential nature of  assembly by showing that 
bases foot-printed by late-assembly proteins show slower kinetics than residues foot-
printed with early binding proteins in the assembly map, in other words, the experiments 
showed a close correlation to the order implied in the assembly map. 
2.2.2.  In vivo 30S Ribosomal Subunit Assembly 
Precursor particles have been isolated during in vivo assembly (Nashimoto et ai., 
1971; Nierhaus et al., 1973; Bryant et al., 1974).  The study of  ribosome assembly in vivo 
has been studied primarily through cold-sensitive mutants defective in ribosome 
assembly (Nashimoto et al., 1971; Bryant et al., 1974) and pulse-labeling experiments 
(Lindahl, 1975).  One precursor particle, designated p 30S, contains all the 30S proteins 
but contains a precursor 16S RNA which is longer at both the 5' and 3' termini than 
mature 16S RNA (Hayes and Hayes, 1971).  This suggests the final step in 16S rRNA 
processing is a late step in subunit maturation.  The mature 5' end of 16S RNA is processed when the precursor RNA is associated with ribosomal proteins (Dahlberg et 
aI.,  1978).  The endonuclease that cleaves the 5' end does not use free RNA as a 
substrate. 
Other precursor particles have mature 16S RNA but do not have a full complement 
of30S proteins.  Since in vitro 30S assembly is strongly temperature dependent, 
Nomura's lab set out to find cold-sensitive mutants that have defects in ribosome 
assembly at low temperatures.  A cold-sensitive mutant (Spc-49-1) has been 
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characterized (Nashimoto et aI.,  1971).  The mutant accumulated 21S particles that had a 
similar protein composition to the RI particle (Table 2.1).  All of  the primary binding 
proteins are present in the mutant 21 S particle.  The mutation was mapped to protein S5 
of  the spc operon.  Other assembly mutants also accumulate 21S particles such as Sad-
410 (Nashimoto et aI.,  1971), even though the mutation did not map in the spc operon.  In 
the case of Sad-410, the protein composition of  the 21 S particle was found to be very 
similar to the Spc-49-1 21 S particle (protein composition of Sad-410 was not published). 
21 S precursor particles have been isolated using hyperbolic gradient sedimentation 
(Nierhaus et aI., 1973).  The isolated in vivo precursor particle is found to be similar to 
the in vitro RI particle with one main difference, S7, S9, S10, S14, and S19 which in vitro 
depend on the presence of S7, is missing from the in vivo precursor (Table 2.1).  Kinetic 
studies of  in vitro assembly have demonstrated that S7 and the others following S7 in the 
assembly map, are late binding proteins during assembly (Powers and Noller, 1993).  The 
isolated in vivo 21 S particle probably is a manifestation of  the kinetics characterized in 
vitro.  The correlation between the in vivo data and the in vitro data derived from these Table 2. I.  Protein content of  reconstitution intermediates of  the 30S 
subunit.+ stands for present, (+) for present in reduced amounts, - not 
present, (-) for not present but required for RI toRI* transition.  Data 
are taken from Nashimoto et al., 1971; Held and Nomura, 1973; and 
Nierhaus et al .,  1973. 
2Is (from Spc-
Protein  RI  P130S  49-1 cells) 
SI  - +  -
S2  - - -
S3  - - -
S4  +  +  + 
S5  (-)  +  -
S6  +  - + 
S7  +  - + 
S8  +  +  + 
S9  +  - (+) 
SlO  - - -
SII  +  - -
S12  (-)  - -
S13  +  +  + 
S14  - - -
S15  +  +  + 
S16  +  +  + 
S17  +  +  + 
SI8  +  - (+) 
S19  (-)  - + 
S20  +  +  + 
S21  - - -
20 21 
different experiments indicates that the sequences of events of  in vitro reconstitution are 
relevant to in vivo assembly. 
2.2.3  Large Subunit 50S Assembly 
Reconstitution of  the 50S subunit can occur in vitro (Nomura and Erdman, 1970; 
Nierhaus and Dohme, 1974; Dohme and Nierhaus, 1976).  Optimal reconstitution of  E. 
coli 50S subunits occurs via a two step process, the first step consists of  incubating the 
components at 4 mM Mg  ++ at 44°C for 20 minutes followed by incubation at 50°C at 20 
mM Mg++ for 90 minutes (Dohme and Nierhaus, 1976).  Through kinetic analysis, it was 
shown that 50S reconstitution occurs via the formula: 
23S RNA + 5S RNA + total protein 50 (TP50) (4 mM Mg++, O°C)  ~RI50(1)  (33S) 
RIso(1) (4 mM Mg++, 44°C) ~RI*so(1)  (41S) 
RI*so(1) + TP50 (4 mM Mg++, 44°C or 20 mM Mg++, 50°C) ~RIso(2)  (48S) 
RIso(2) (20 mM Mg++, 50°C) ~50S 
It has three intermediates, RIso(1) which sediments at 33S and is present at O°C, RI*so(1), 
that sediments at 41 S, is the essential product of  the first incubation step, it cannot be by-
passed in the second step, and it contains the same proteins as the RIso(1) despite the 
drastic change in sedimentation value, and RIso(2) which sediments at 48S.  It was further 
demonstrated that RIso(1)  ~RI*so(l) and RIso(2) ~50  S are the rate-limiting reactions 
for each of  the steps and are unimolecular (Sieber and Nierhaus, 1978). 
Using a similar technique as taken for the 30S subunit, an assembly map for the E. 
coli 50S subunit has been constructed by Nierhaus and co-workers (R6hl and Nierhaus, 
1982; R6hl et at.,  1982; Harold and Nierhaus, 1987).  The assembly map is more 
complex due to the multiple steps with different reaction conditions and the greater 22 
number of  components.  Ll, L2, L3, L4, (LI2)4-L10, Lll, LIS, L20, L23, and L24 bind 
directly and independently to the 23S RNA.  L5, L18, and L25 bind to the 5S RNA.  Of 
these, proteins L24 and L3  initiate 50S ribosomal assembly in a domain like fashion 
(Nowotny and Nierhaus, 1982). The 23S RNA and five proteins, L4, L13, L20, L22, and 
L24 (with L3  having a stimulatory effect) are essential for the RI*5o(l) formation.  These 
proteins except L3  also bind towards the 5' end of  the 23S RNA.  The proteins, which 
bind early in assembly, also have the ability to bind 23S RNA before synthesis of  the 23S 
RNA is complete.  This coupling ofrRNA synthesis and ribosomal assembly is termed 
assembly gradient (Sieber and Nierhaus, 1978).  In vivo assembly starts with a short 
section of  RNA and 5 proteins instead of  the mature 23S RNA being exposed to all L-
proteins as is the case with in vitro assembly and could explain why in vivo 50S assembly 
takes a few minutes at 37°C and 90 minutes at 50°C in vitro (Nierhaus, 1991). 
In vivo precursor particles have also been studied for the 50S subunit.  In vivo 
assembly occurs via three precursor particles: the P150S which sediments at 34S. the 
P250S that sediments at 43 S, and the P350S which sediments 'near 50S'.  The P350S 
precursor contains all the L-proteins, similar to the RIso(2) reconstitution intermediate. 
The protein contents of  the P150S and the P250S as well as the RIso(1) are shown in Table 
2.2.  The early group of  in vitro assembly proteins belongs to the first ten proteins in in 
vivo assembly and are present in the PI 50S precursor.  The proteins missing from the 
P150S precursor which would correspond to the late assembly proteins in vitro do not 
agree as well.  Assembly in vitro and in vivo start by similar pathways but diverge 
towards the end of  the pathways (Spillman et aI.,  1977). Table 2.2.  Protein composition of in vivo  precursor particles and in 
vitro  reconstitution intermediates of  the 50S subunit.  Data for RI  so( I) 
taken from Harold and Nierhaus, 1987 and Nierhaus et al .,  1973 for the 
precursor particles, p 150S and P250S.  L8 is the pentamer 
L 1O(L7/L 12)4 and is not shown, L26 is the 30S protein S20 and is not 
shown.  L34, L35, L36 have not been assigned. 
Protein  plSOS  P2S0S  RIso(l) 
lL  +  +  + 
L2  - - (+) 
L3  +  +  + 
L4  +  +  + 
L5  +  +  + 
L6  - - -
L7ILI2  (+)  +  + 
L9  +  +  + 
LIO  +  +  + 
LII  (+)  +  + 
L13  +  +  (+) 
LI4  - +  -
L15  - +  + 
L16  - - -
L17  +  +  + 
LI8  +  +  (+) 
LI9  - +  -
L20  +  +  + 
L2I  +  +  + 
L22  +  +  + 
L23  +  +  + 
L24  +  +  + 
L25  +  +  -
L27  +  +  -
L28  - - -
L29  +  +  + 
L30  +  +  -
L3I  - - -
L32  - - -
L33  - +  (+) 
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2.3  Small Ribosomal Subunit Protein S8 and its 16S RNA Binding Site 
2.3.1  Small Ribosomal Subunit Protein S8 
Ribosomal protein S8 is one of  the primary ribosomal binding proteins to the 16S 
RNA. It binds to the 16S RNA with high affinity and in the absence of  other proteins.  S8 
is about 130 amino acids long, depending on the species.  In E.  coli, S8 is 129 amino 
acids long with a molecular weight of 14,000 daltons (Allen and Wittman-Leibold, 
1978).  S8 is a basic protein with an isoelectric point of  9.1  in E.  coli (Kaltschmidt, 
1971).  According to cross-linking data (Tindall and Aune, 1981; Lambert et ai.,  1983) 
and neutron diffraction studies (Capel et ai., 1987), the protein neighbors of  S8 are S2, 
S4, SS, S12, SIS, and S17 in the 30S subunit. 
Two crystal structures have been determined for S8, one from Bacillus 
stearothermophilus (Davies et ai., 1996) and one from Thermus thermophilus (Nevskaya 
et ai., 1998).  The overall crystal structures are closely related.  S8 is a globular protein 
and consists of  two domains that are independently folded and tightly associated.  The 
domains are connected by an interdomain loop that varies in length among species but 
does not display flexibility in the structures.  Based on the crystal structures, there are 
three proposed functional sites on protein S8.  One is located on the N-terminal domain 
and is bordered by positive potential.  The site is generally conserved and is proposed to 
be a secondary RNA binding site that has also been suggested through chemical probe 
studies (Stern et aI, 1989) and hydroxyl radical foot-printing (Powers and Noller, 1995). 
Another proposed functional site is a conserved, concave hydrophobic patch flanked by 
two basic regions located in the C-terminal domain.  It has been proposed that this site is 
a protein-protein interaction site and the best candidate for this interaction is protein SS. --------------------------- ~~~-~~~------
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Protein S5 has been shown to be one of  the nearest neighbors to protein S8 in the 
ribosome (Tindall and Aune, 1981; Lambert et aI.,  1983; Capel et aI.,  1987).  The crystal 
structure for S5 has also been determined (Ramakrishnan and White, 1992) and it has 
been shown to have a convex hydrophobic patch which is approximately equal in size 
and generally complementary in shape to the hydrophobic patch of  S8 (Davies et aI., 
1996). 
The third functional site lies in the C-terminal portion of  the C-terminal domain and 
is proposed to be the primary RNA binding site.  The crystal structures for S8 can be 
aligned very accurately in this region (Nevskaya et aI., 1998).  Several residues are 
completely conserved including basic amino acids potentially involved in RNA 
phosphate backbone interactions and aromatic amino acids potentially involved in 
specific base interactions.  Mutational experiments have been performed where the N-
terminal 51  amino acids have been removed from the protein and the protein still retains 
specific binding albeit with lower affinity (Uma et aI., 1995).  Mutations in the C-
terminal portion of  the protein resulted in the most severe impairment of  binding to the 
main 16S RNA site and removal of  the last 8 amino acids of  the C-terminus resulted in a 
severe reduction of  binding to the RNA (Wower et aI., 1992; Uma et aI.,  1995). 
2.3.2  The Binding Site of  Protein S8 and the Binding to the 16S RNA 
The primary RNA binding site of  protein S8 is a short double strand imperfect 
helical sequence (helix 21) on the 16S RNA between nucleotides 590-650, E  coli 
numbering (Figure 2.3) (Schaup et aI.,  1973; Ungewickell et aI.,  1975; Zimmermann et 
aI., 1975).  Through filter-binding assays, the apparent association constant for the 
binding ofS8 to its binding site ranges between 2.7 and 5 x 10
7 Ml (Schwarzbauer and 26 
Figure 2.3.  Primary and secondary structure of  E.  coli helix 21, the S8 binding site, of 
the 16S RNA.  A.  Secondary structure according to Gutell, 1996.  The core S8 binding 
site is boxed.  B.  Structure of  the core S8 binding site of  E.  coli.  The 
AS9S.(AS96.U644) base triple identified by NMR studies and supported by phylogenetic 
comparison is boxed.  The bases involved in the base triple suggested by NMR and by 
hydroxyl radical studies but not supported by sequence comparison are double 
underscored. A 
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Craven, 1981; Mougel et aI.,  1986) and 4 x 10
7 Ml using a sedimentation assay (Mougel 
et aI.,  1986).  The size of  the loop is variable (Gutell et aI.,  1985).  In eubacteria and 
archaebacteria the length of  the loop remains mostly constant.  In mitochondria the helix 
ranges from one base pair shorter (in plants) to completely deleted (bovine).  In 
eukaryotic cytoplasmic 16S-like-RNA, there's a 225-nucleotide insertion (Winker and 
Woese, 1991).  The minimal binding site has been further delineated to include only a 
portion of helix 21, nucleotides G588 to G605 and C633 to C651 E,  coli numbering 
(Mougel et aI.,  1993; Wu et aI.,  1994).  The binding site consists of  the asymmetric 
region C of  nine nucleotides surrounded by a base-paired helix (Figure 2.3 B).  Eight of 
the nine nucleotides are conserved (Gutell, 1993). 
To elucidate the fine structure of  the S8 binding site, the site has been studied 
extensively and by a number of  methods including site directed mutagenesis, chemical 
footprinting, hydroxyl radical footprinting, SELEX (Moine et aI., 1997), and nuclear 
magnetic resonance spectroscopy (NMR) (Kalurachchi et aI.,  1997; Kalurachchi and 
Nikonowicz, 1998).  On the basis of  chemical probing experiments (Mougel et aI.,  1987) 
a non-canonical, U598-U641 basepair was suggested but is not supported by NMR 
experiments (Kalurachchi et aI.,  1997) nor sequence comparison models (Gutell, 1996). 
Both NMR and SELEX (Moine et aI.,  1997) support a base triple between 
U641'(G597'C643) but the base triple is not supported by comparative analysis.  A base 
triple between A595'(A596'U644) has been identified by NMR and is also predicted by 
comparative phylogenetic evidence.  The deletion of  A595 severely retards the binding of 
protein S8 (Mougel et aI.,  1993) suggesting that the formation of  this structure is essential 
for S8 binding. 29 
Mutational analysis has established that helices of  several basepairs in length 
surrounding the core are needed for efficient S8 association (Wu et aI., 1994).  According 
to NMR studies, protein S8 may form nonspecific contacts with based U591  and G650 at 
the base of  the helix possibly involving the phosphate backbone.  The base of  the helix 
has also been cross-linked to protein S8 (Wower and Brimacombe, 1983).  NMR has also 
shown that protein binding occur without significant alterations to the core RNA 
structure. 
2.4 Ribosomal RNA (rRNA) Operons and the spc Operon 
2.4.1.  rRNA Operons 
There are seven rRNA operons (designated rrnA through rrnH except there is no 
rrnr) in E.  coli.  The rRNAs encoded by them are similar.  Each operon contains 16S, 
23S, and 5S genes in that order (Figure 2.4 A).  Between the 16S and 23S and in some 
operons, at the end of  the transcipts, lie tRNA genes.  The direction of  transcription of 
rRNA genes matches that of  replication, probably to avoid collisions with the replication 
machinery.  The replication machinery does indeed displace RNA polymerase as it passes 
through the rRNA genes.  The progress of  the replication fork is significantly impeded 
when an active rRNA operon and replication are in opposite directions (French, 1992) 
There are two promoter regions upstream of  the 16S RNA gene in all operons and 
they are designated PI and P2 (Figure 2.4 B).  For all promoters, the -10 region matches 
exactly the consensus sequence for recognition by RNA polymerase (TAT  AAT) (Keener 
and Nomura, 1996).  The -35 region varies slightly from the consensus and there is only 
16 base pairs in between the two regions verses 17 base pairs for the consensus.  The 30 
Figure 2.4.  Generic structure of  a ribosomal operon in E.  coli.  A.  The coding region for 
the mature rRNAs.  B.  The PI promoter region expanded to show the FIS binding sites, 
the UP element and the core promoter region (the -35 and -10 region). 31 
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addition of  one base pair to the spacer region and mutations that change the -35 region to 
that of  the consensus, greatly increase promoter activity but abolish growth-rate control 
of  transcription.  Growth rate control is characterized by the synthesis ofrRNA as a 
consequence of  growth in media of  different nutritional qualities and conditions that 
result in a variation of  growth rates.  These promoter sequences have evolved for 
regulation and optimal growth under changing conditions as well as high activity. 
The P 1 promoter of  the rrnB operon contains an upstream element (UP element) 
that increases rrnB activity by a factor of  30 in the absence of  protein factors other than 
RNA polymerase (Ross et aI., 1993).  It is a 20-base pair region between -40 and-60 
that is AT rich.  It binds the a subunit of  RNA polymerase.  Other PI promoters also 
have sequences rich in AT in this region and probably are UP elements as well.  The PI 
promoter also contains three Factor for Inversion Stimulation (FIS) binding sites 
upstream of  the UP element between bases -60 to -150 (Ross et aI., 1990). 
Under rapid growth conditions, rRNA synthesis occurs mostly from the rrn PI 
promoters (Sarmientos et aI., 1983) and is sensitive to growth-rate control and stringent 
control.  Stringent control is characterized by the repression ofrRNA synthesis and an 
increase in guanosine tetraphosphate during amino acid starvation.  The rrn P2 promoters 
contribute little to the total rRNA transcription at high growth rates (de Boer and 
Nomura, 1979) but are thought to be basal contributors to rRNA synthesis.  These have 
been shown to be insensitive to growth-rate control but are sensitive to stringent control. 
2.4.2.  spe Operon 
The spe operon is a polycistronic message that codes for ribosomal and non-
ribosomal proteins.  It is localized at the classic str locus at 73 minutes on the E.  eoli 33 
chromosome between the S 10 operon and the a operon (Nomura et aI.,  1984; Lindahl 
and Zengel, 1986).  The order of  genes in the E.  coli spc operon is L14, L24, LS,  S14, S8, 
L6, L 18, S5, L30, LIS, secY, and L36 (Figure 2.A) (Ceretti et aI.,  1983; Ueguchi et aI., 
1989).  Transcription of  the spc operon is initiated at a promoter site in the 163- basepair 
region between the last gene of  the S 1 °  operon (S 17) and the first gene of  the spc operon 
(LI4) (Post et aI.,  1978).  Read through of  the S10 operon into the spc operon has been 
observed (Henkin et aI.,  1989). 
Expression of  the proteins of  the spc operon is autogenously regulated post-
transcriptionally by the binding of  excess protein S8 to a target sequence located at the 
beginning of  the L5 gene.  This produces translational repression ofL5 and through 
translational coupling, also represses the genes downstream to L5 (Dean et aI., 1981; 
Cerretti et aI., 1988).  Protein S8 also inhibits the synthesis of  protein L14, L24, and L5 
by inducing endonucleoytic cleavage downstream of  the mRNA target site followed by 
3'  -S' exonucleolytic degradation (Mattheakis et aI.,  1989). 
Regulation of  the spc operon in E.  coli is mediated by the binding of  protein S8 to 
the target mRNA of  the L5 gene (Figure 2.5).  Most of  the regulation element lies at the 
LS  AUG start site and in the gene itself (Cerretti et aI., 1988).  Through structure-specific 
nuclease studies and computer-generated models, a structure for the regulatory binding 
site has been proposed (Figure 2.S B).  There is a primary and secondary structure 
similarity between the mRNA and rRNA binding sites (compare Figure 2.3 with Figure 
2.5) suggesting that the binding of  S8 is mediated by the same elements of  the protein. 
There are differences in the mRNA and rRNA structures in particular, the bases C955 
and U952 that are bulged in the mRNA.  Deletion experiments in the mRNA and 34 
Figure 2.5.  Features of  the spc operon.  A.  Transcriptional unit of  the spc operon. 
Promoter is designated as P.  Open reading frames of  proteins are boxed. Genes are in 
order from left to right. The regulatory S8 binding site is marked. B.  The primary and 
secondary structure of  the S8 binding site at the translational start site of  protein L5.  The 
translational start site (AUG) is boxed.  The structure is that proposed by Cerretti et ai., 
1988.  Compare with figure 2.3. --------------------------------------------------
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35 insertion experiments in the rRNA have confirmed that these bulged bases modulate the 
strength of S8-RNA interactions.  The affinity for the rRNA is approximately fivefold 
higher than the mRNA (Wu et a/.,  1994). 
36 Chapter 3 
Materials and Methods 
3.1.  Growth Curve Studies and Northern Blot Analysis 
3.1.1  Phage  mid Preparation containing S8 Binding Site, PBSS842-2 and 
Transformation into Bacterial Cells 
Oligoribonucleotides do not penetrate well into bacterial cells.  Therefore, to study 
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the in vivo effects of  the S8-RNA binding site, a phagemid containing the S8 binding site 
under a lacZ promoter was constructed and transformed into bacterial cells as described 
in the following paragraphs.  The S8 binding site RNA was then produced by induction 
of  the lacZ gene with IPTG.  Growth and RNA were then monitored. 
DNA homologous to the S8 binding site on the 16S RNA (bases 590-648 with bases 
610-627 deleted, E.  coli numbering) and its complement were synthesized by the Center 
for Gene Research and Biotechnology, Oregon State University.  The sequences were 
42S8-5 (5'  -AGC TTT GTT AAG TCA GAT GTG AAA GAA CTG CAT CTG AT A 
CTG GCA ACT GCA-3') and 42S8-3 (5'-GTT GCC AGT ATC AGA TGC AGT TCT 
TTC AGA TCT GAC TTA ACA A-3 ').  They had restriction endonuclease sites 
synthesized on the ends so they could be ligated into the phagemid.  The synthetic DNA 
was rehydrated and loaded onto a Sephadex G25 (Pharmacia, Piscataway, NJ) column to 
desalt and to remove failure sequences.  One-ml fractions were collected by using a 
Gilson fraction collector (Middleton, WI) and were monitored spectrophotometrically at 
260 nm.  Fractions containing the highest A260 readings were pooled and dried down overnight using a LabConco Cenrivap Concentrator (Kansas City, MS).  100 III of 
autoclaved distilled water was added and the concentration was determined. 
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One nanomole of  each strand of  DNA was subjected to a polynucleotide kinase 
reaction (New England Biolabs, Beverly, MA).  The reaction mixtures were pooled and 
the temperature raised to 98°C and remained above 85°C for 10 minutes to inactivate the 
kinase; then the strands were allowed to cool and anneal overnight. 
One Ilg of  the PBS+ phagemid (Stratagene, La Jolla, CA) was subjected to 
endonuclease restriction enzyme digestion using Pst I and Hind III (New England 
Biolabs, Beverly, MA) then subjected to filtration using a Microcon 30 (Ami  con, 
Beverly, MA) to remove the small sequence between the restriction sites from the 
mixture.  The efficiency of  the cut phagemid was monitored by gel electrophoresis using 
a 1 % agarose 45 mM Tris-borate-l mM EDT  A (TBE) horizontal gel.  Uncut PBS+ 
phagemid was used as a control.  The fragments were visualized by ethidium bromide 
staining.  The efficiency was found to be 100 % by visualization. 
0.05 picomoles of  cut PBS+ phagemid DNA (0.1  Ilg) and 0.5 picomoles of  double 
stranded synthetic DNA were subjected to a ligation reaction (New England Biolabs, 
Beverly, MA).  As a control, cut PBS+ phagemid DNA with no synthetic DNA was also 
subjected to a ligation reaction. 
XLI-MRF' Blue E.  coli (Stratagene, La Jolla, CA) was transformed with PBSS842-
2 phagemid using the CaCh-heat shock method described by Sambrook et at.  (1989a). 
Transformed cells were plated onto 100 x IS mm Luria-Bertani (LB) agar plates 
containing 12.5 Ilglml tetracycline and 60 Ilglml ampicillin.  XLI-MRF' Blue are 
tetracycline resistant and the PBS+ phagemid has an ampicillin resistance marker on it. 39 
The plates were inverted and incubated overnight at 37°C.  The transformed cells were 
then replicate plated onto 100 x IS  mm S-bromo-4-chloro-3-indolyl-p-D-galactoside (X-
gal)-IPTG-LB agar plates containing 12.S  Ilglml tetracycline and 60 Ilglml ampicillin. 
Insert and non-insert-containing colonies were identified by blue-white screening; those 
without the insert were blue due to cleavage of  X-gal by p-galactosidase.  Insert-
containing colonies were white due to inactivation of p-galactosidase and the inability to 
cleave X-gal.  Select colonies were incubated overnight in LB medium containing 12.S 
Ilglml tetracycline and 60 Ilglml ampicillin at 37°C with vigorous shaking (200 r.p.m. on 
a rotary shaker).  Phagemids were isolated from the cells according to Sambrook et al. 
(1989b) and subjected to restriction enzyme analysis on a 3.0 % Metaphor agarose (FMC 
BioProducts, Rockland, ME) gel in TBE buffer to confirm the insert.  Two types of 
candidates were isolated, one with a putative triple sequence insert and was named 
PBSS842-1 and others with a putative single sequence insert named PBSS842-2. 
Colonies with the putative inserts were cultured overnight in LB medium containing 12.S 
Ilglml tetracycline and 60 Ilglml ampicillin at 37°C with vigorous shaking (200 r.p.rn. on 
a rotary shaker).  The phagemids were purified from cells by using a Qiagen-tip 20 anion-
exchange column and plasmid purification protocol (Qiagen, Thousand Oaks, CA). 
Sequence analysis was performed by the Center for Gene Research and Biotechnology, 
Oregon State University.  The cell line DHSa. was also transformed with the phagemid. 
3.1.2  Deletion of  the Shine-Dalgarno Sequence and Translational Start Site From 
PBSS842-2 Phagemid with the S8 Binding Site and Transformation into Bacterial 
Cells 
To ensure ribosomes could not bind to the message and unfold the RNA secondary 
structure, the Shine-Dalgarno sequence and the translational start site from the PBSS842-40 
2 lacZ gene was deleted using polymerase chain reaction (PCR) techniques.  Primers 
lac+27 (S'-GTG TGA AAT TGT TAT CCG CT-3') and lac+S8 (S'-CTC GAA ATT 
AAC CCT CAC TA-3') were synthesized by the Center for Gene Research and 
Biotechnology, Oregon State University.  The primer lac+27 is complementary to coding 
nucleotide sequence +8 to +27 and lac+S8 is complementary to +S9 to +78 of  the lacZ 
gene on the PBS+ phagemid.  Final concentrations of  the IOO-1l1 reaction mixture were 
IX buffer, 2.S units Taq DNA Polymerase (Life Technologies, Gaithersburg, MD), 0.2 
mM each dNTP, 2.0 mM MgCh, O.S  IlM each primer, and 10 ng PBSS842-2 used as a 
template.  Thermal cycling parameters are shown in Table 3.1.  PCR products were 
resolved on a 1.0 % agarose TBE horizontal gel and visualized by ethidium bromide 
staining.  PCR products were phenol: chloroform extracted and passed through a 
microcon 30 (Ami  con, Beverly, MA) to remove polymerase and primers.  The PCR 
products were then subjected to Klenow fragment (Promega, Madison, WI) reaction to 
generate blunt ends and ligated together with T4 DNA ligase (New England Biolabs, 
Beverly, MA) to generate a circular phagemid similar to PBSS842-2 but with a 3I-base-
pair deletion (L1PBSS842-2). 
XLI-MRF' Blue E.coli (Stratagene, La Jolla, CA) cultures were transformed with 
~PBSS842-2  phagemid by using the CaCh-heat shock method described by Sambrook et 
al.  (1989a).  Transformed cells were plated onto 100 x IS mm-LB agar plates containing 
12.S Ilg/ml tetracycline and 60 Ilg/ml ampicillin.  The plates were inverted and incubated 
overnight at 37°C.  Select colonies were incubated overnight in LB medium containing 
12.S Ilg/ml tetracycline and 60 Ilg/ml ampicillin at 37°C with vigorous shaking (200 
r.p.m. on a rotary shaker).  Phagemids were isolated from the cells according to Table 3.1.  Thermocycling parameters for PCR used to delete the Shine-Dalgarno 
and translational start site of  the lacZ gene from the PBS+ phagemid with S8 
insert (PBSS842-2). 
Cycles  Step  Temperature  Time 
Denature  94°C  3 minutes 
1  Anneal  62°C  30 seconds 
Extend  72°C  90 seconds 
Denature  94°C  45 seconds 
35  Anneal  62°C  30 seconds 
Extend  72°C  90 seconds 
1  Extend  72°C  10 minutes 
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Sambrook et at.  (1989b) and subjected to restriction enzyme analysis on 3.0 % Metaphor 
agarose gel in TBE buffer to confirm the deletion.  A colony of  cells containing the 
putative deletion was cultured overnight in LB medium containing 12.5  ~g1ml 
tetracycline and 60  ~g1ml ampicillin at 37°C with vigorous shaking (200 r.p.m. on a 
rotary shaker).  The ,1PBSS842-2 phagemid was purified from cells using Qiagen-tip 20 
anion-exchange column and plasmid purification protocol (Qiagen, Thousand Oaks, CA). 
Sequence analysis was performed by the Center for Gene Research and Biotechnology, 
Oregon State University. 
3. 1.3  Growth Curve Analysis 
Cells with cloned phagemids were cultured overnight in LB medium containing 
12.5  ~g1ml tetracycline and 60  ~g1ml ampicillin at 37°C with vigorous shaking (200 
r.p.m. on a rotary shaker).  These overnights were used to inoculate cultures that were 
grown in the presence or absence ofIPTG at 200 r.p.m. on a rotary shaker.  Conditions 
for the growth curves are shown in Table 3.2.  Growth was monitored 
spectrophotometrically at 600 nm.  Thiamine was added to the M9 medium for the XL 1-
MRF' cell line. 
3.1.4  Northern Blot Analysis 
To analyze phagemid mRNA levels, a 30-base oligonucleotide probe named lacZ 
was synthesized by the Center for Gene Research and Biotechnology, Oregon State 
University.  The probe sequence:  5'  -GT A AAA CGA CGG CCA GTG AAT TGT AAT 
ACG-3' is complementary to + 164 to + 194 of  the lacZ transcriptional start site on the 
PBS+ phagemid.  The synthesized sequence 42S8-3 complementary to the insert on the Table 3.2.  Conditions used in growth experiments. 
Temperature  Culture Volume  Inoculation 
Phagmid  Cell Type  (OC)  Media  (ml)  Volume (ml) 
PBSS842-1  XLI-MRF'  37  LB  50  0.5 
PBSS842-1  XLI-MRF'  37  LB  50  1.0 
PBSS842-2  XLI-MRF'  37  LB  50  1.0 
PBS+  XLI-MRF'  37  LB  50  1.0 
tlPBSS842-2  XLI-MRF'  37  LB  50  1.0 
MBSS842-2  XLI-MRF'  24  M9  200  1.0 
PBSS842-2  XLI-MRF'  24  M9  200  1.0 
PBSS842-2  DH5a  24  M9  200  1.0 
MBSS842-2  DH5a  24  M9  200  1.0 
tlPBSS842-2  XLI-MRF'  24  M9  200  1.0 
tlPBSS842-2  DH5a  24  M9  200  1.0 
tlPBSS842-2  DH5a  24  M9  200  1.0 
tlPBSS842-2*  DH5a  24  M9  200  1.0 
PBSS842-2  DH5a  24  M9  200  1.0 
PBSS842-2*  DH5a  24  M9  200  1.0 
* IPTG added at o. 4 ~oo  units. PBSS842-2 and L1PBSS842-2 phagemid, called the S8 probe, was also used as a probe. 
Following synthesis, the lacZ probe was rehydrated in diethylpyrocarbonate (DEPC)-
treated autoclaved water and both probes were 5' end-radiolabeled by using ye
2p] ATP 
(6000 Cilmmol, New England Nuclear, Boston, MA).  The end-labeled probes were 
separated from free y[32p] ATP by filtration through a Centricon 3 (Amicon, Beverly, 
MA) (Sambrook et aI.,  1989c).  The probes were end-labeled to a specific activity of 
approximately 10
8_10
9 cpm//lg. 
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Total RNA was extracted from XLI-MRF' E.  coli cells according to the method of 
Reddy (1993).  Cells were grown to 0.6 Atioo units in LB medium with 12.5 /lg/ml 
tetracycline and 60 /lg/ml ampicillin (tetracycline only for XLI-MRF' cells with no 
phagemid) in the presence or absence of  IPTG.  The cells were shaken vigorously at 
37°C.  15 ml of  culture was used to isolate RNA.  Concentration was determined 
spectrophotometrically at 260 nm.  The protein content of  the RNA was monitored by 
A260/A280 nm ratio.  Total RNA was analyzed by using a l.0 % agarosel2.2 M 
fomaldehyde gel.  The quality of  RNA was checked by ethidium bromide staining to 
verify 16S and 23 S bands.  Gels were washed in distilled water then in lOX SSC (1.5 M 
NaCI, 0.15 M trisodium citrate).  The RNA was transferred overnight to a Zeta-probe 
membrane (Biorad, Richmond, CA).  The membrane was rinsed briefly, and then the 
RNA was fixed to the membrane by baking at 80°C for 30 minutes.  The membrane was 
pre-hybridized overnight at 50°C in hybridization buffer [20 mM Na2HP04, pH 7.2, 5X 
SSC, 7 % sodium dodecyl sulfate (SDS), IX Denhardt's and 100 /lg/ml denatured salmon 
sperm DNA].  Following pre-hybridization, the blot was hybridized for 24 hours to the 
5'e2p] end-labeled oligonucleotide probes in hybridization buffer at 50°C.  Following hybridization, the membrane was washed twice at 50°C for 30 minutes in 3X SSC, lOX 
Denhardt's, 5 % SDS and 25 mM Na2HP04, pH 7.5, and washed once at 50°C for 30 
minutes in IX SSC and 1.0 % SDS.  The blot was then sealed in a plastic bag and 
autoradiographed with Dupont Cronex intensifying screens and Kodak X-Omat film at 
room temperature.  The blots were then stripped by washing 2-3 times at 95°C in O.IX 
SSC, 0.5 % SDS and the membranes were reprobed as needed. 
3.2.  Reconstitution Studies 
3.2.1  Purification of  70S Ribosomes, Ribosomal Subunits, and S-150 Enzymes 
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Using a modification of  the methods described by Nierhaus (1990), 70S 
ribosomes and ribosomal subunits were isolated.  Strain D 1  0 E.  coli was grown in LB 
medium at 37°C with vigorous shaking to 0.5  ~oo  units.  The cells were harvested and 
centrifuged at 5000 g for 10 minutes.  Pelleted cells were stored at -80°C.  All subsequent 
steps were performed between 0-4°C. 
Cells were thawed in 1:2 (w/v) buffer 3 [20 mM Hepes pH 7.6 at O°C, 4 mM 
MgCh, 30 mM ~CI,  2 mM spermidine, 0.2 mM spermine, 3 mM dithiothreitol (DTT)] 
and centrifuged at 5000 gfor 10 minutes. The pellet was resuspended in 1:2 (w/v) buffer 
3 and deoxyribonuclease (Worthington Biochemical, Freehold, NJ) was added to 5 
~g/ml.  The cells were disrupted in a French press at 15,000 p.s.i.  The extract was 
centrifuged at 10,000 g for 10 minutes then 30,000 g for 40 minutes to remove cell 
debris.  The supernatant was centrifuged for 4 hours at 40,000 r.p.m. in a Beckman 
(Beckman, Palo Alto, CA) SW 55 Ti rotor to pellet the ribosomes. To obtain S-150 enzymes the supernatant was centrifuged at 150,000 g for 3 
hours.  The upper two-thirds of  the supernatant was used as S-150 enzymes.  Protein 
concentration of  the S-150 enzymes was determined as described by Bradford (1976), 
with bovine serum albumin as a standard. 
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The ribosomal pellet was resuspended in gradient buffer (0.01 M Tris pH 7.6, 
0.05 M KCI, 0.3 mM MgCh, 4 mM DTT) and dialyzed overnight in 100 volumes of  the 
same buffer.  About 300 A260 units were subjected to zone centrifugation in 15-30 % 
linear sucrose gradients in gradient buffer at 27,000 r.p.m. using a Sorvall (Newtown, 
CT) AH-627 rotor for 14 hours.  About 30 fractions were collected per gradient and 
aliquots of  the fractions were measured spectrophotometrically at 260 nm.  Fractions 
containing 30S and 50S subunits respectively were pooled and a 2: 1 (v/v) 95 % ice-cold 
ethanol solution was added while stirring to precipitate the subunits.  The suspensions 
were stored minimally overnight at -20°C and then centrifuged at 10,000 g for 40 
minutes.  The pellets were washed with ice cold 70 % ethanol, resuspended in gradient 
buffer and subjected again to zone centrifugation under the previous conditions.  The 
pellets were resuspended in buffer 3 to about 300 A260 units/ml, clarified by low speed 
centrifugation, and the solutions were stored at -80°C. 
3.2.2  Purification of30S Proteins and 16S RNA 
30S proteins (TP30) and 16S rRNA were isolated from purified 30S particles as 
previously described (Nierhaus, 1990).  30S subunits in buffer 3 (concentration of  300 
A260 units/ml or less) were stirred with 0.1 volume of 1 M Mg acetate and 2 volumes 
glacial acetic acid for 45 minutes at O°C then centrifuged at 10,000 g for 30 minutes. 
Five volumes of  acetone were added to the supernatant and the mixture was stored 47 
minimally overnight at -20°e.  The suspension was centrifuged at 10,000 g for 30 
minutes.  The pellet was placed in a desiccator for about 15 minutes to remove the 
residual acetone then it was resuspended in buffer 5 (6 M urea, 20 mM Tris-HCI pH 7.4, 
4 mM Mg acetate, 400 mM NH4CI, 0.2 mM EDT  A, 4 mM DTT) to a concentration of 
about 300 equivalent A260 units (e.u.)/ml.  It was dialyzed in buffer 5 overnight then was 
dialyzed 3 times against 100 volumes of  buffer 4 for 45 minutes each.  Concentration was 
determined spectrophotometrically at 230 nm using the conversion factor of 1 A230 unit 
TP30 =  8 e.u. and the solution was stored in small aliquots at -80°C. 
16S rRNA was purified from 30S subunits by the addition of  0.1  volume of 10 % 
(w/v) SDS, 0.05 volume of2 % (w/v) bentonite, and 1.0 volume of  water-saturated 
phenol.  The mixture was mixed for 10 minutes and then was centrifuged at 10,000 g for 
10 minutes. 1.0 volume of  water-saturated phenol was added to the upper aqueous phase 
and mixed for 10 minutes.  The mixture was centrifuged for 10 minutes at 10,000 g.  The 
upper aqueous phase was removed and 2 volumes of95 % ice-cold ethanol were added to 
precipitate the RNA.  The suspension was stored at -20°C overnight.  The mixture was 
centrifuged for 45 minutes at 10,000 g.  The pellet was washed with 70 % ice-cold 
ethanol to remove traces of  phenol then resuspended in buffer 7 (10 mM Tris-HCl, pH 
7.6 at O°C, 4 mM Mg acetate).  The concentration was determined spectrophotometrically 
at 260 nm, and the solution stored in small aliquots at -80°C. 
3.2.3  Preparation of  Oligoribonucleotides 
Oligoribonucleotides CT4, CTIO, and CTll (Table 3.3) were synthesized and gel 
purified by Oligo Therapeutics (Wilsonville, OR).  The oligoribonucleotides were ,-------------------------------------------------------------------------- .--------------
Table 3.3.  Sequences of  oligoribonucleotides used in reconstitution experiments. 
Name  Sequence (5'-3') 
----------------------------~  16S RNA (590-648) 
CT 10* 
UUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCACCUGGGAACUGCAUCUGAUACUGGCAA 
CT 11 * 
CT4 
GUUUGUUAAGUCAGAUG 
GGUUUGUAAGUCGAGAUG 
* The 3' end nucleotide is a DNA. 
GCAACAUCUGAUACUGGCAAGCC 
GCAACAUCUUGAAACUGCAAGCC 
CAUCUGAUACUGGCAA 49 
shipped lyophilized and stored lyophilized at -80°C until ready to use.  The 
oligoribonucleotides were rehydrated in DEPC-treated autoclaved water.  The 
concentration was determined spectrophotometrically at 260 nm.  The 
oligoribonucleotides were checked for purity by 5'end-Iabeling using T4 polynucleotide 
kinase and running on a 12 % polyacrylamide/6 M urea gel.  1 pmole of 
oligoribonucleotide was incubated with 50,000 cpm 'Y e
2p] ATP (New England Nuclear, 
Boston, MA), 10 units ofT4 polynucleotide kinase (Sigma Chemicals, St. Louis, MI), IX 
kinase buffer and DEPC-treated water to 10 ~  for 1 hour at 37°C.  The reaction mixtures 
were loaded onto a 12 % polyacrylamide denaturing gel (Sambrook, et al., 1989d) and 
electrophoresed for 3 hours at 200V.  The gel was autoradiographed by using Kodak X-
Omat film.  Typical exposure times were 24 hours. 
3.2.4  Reconstitution of30S Subunits 
Reconstitutions of  30S subunits were performed similarly to those ofNierhaus 
(1990).  In 50-J11 reaction mixtures, 0.625 e.u. of  TP30 in Buffer 4 (20 mM Tris pH 7.4 at 
O°C, 4 mM Mg acetate, 400 mM NH4CI, 0.2 mM EDTA, 4 mM DTT), enough buffer 4 to 
bring the total volume to 50 ~,  and 2 ~  of  0.4 M Mg acetate in the presence or absence 
of  the oligoribonucleotide.  The reaction was allowed to proceed for 10 minutes at 40°C, 
then the mixture was put on ice.  0.625 A260 units of 16S rRNA in buffer 4 was added, 
and the reaction mixture incubated for an additional 20 minutes at 40°C, then put on ice. 
40-J11 aliquots (0.5 A260 units) were measured for activity in the polyphenylalanine 
synthesis assay. 50 
3.2.5  Polyphenylalanine Synthesis Assay 
Polyphenylalanine synthesis assays were performed using a modification of 
Spedding (1990) and Nierhaus (1990).  A volume of  40 J1l  containing 0.5 A260 units of 
reconstituted 30S particles in the presence or absence of  oligoribonucleotides, or 40 J1l of 
buffer 6 as a negative control, or 0.5 A260 units of  non-reconstituted 30S particles as a 
positive control, was added to the polyphenylalanine synthesis assay.  The ionic 
conditions of  the assay were 20 mM Tris, pH 7.8 at O°C,  11  mM Mg acetate, 160 mM 
NH4CI, and 4 mM ~-mercaptoethanol. The assay mixture also contained 1.5 mM ATP 
(Boehringer Mannheim, Germany), 0.05 mM GTP (Boehringer Mannheim, Germany), 5 
mM phosphoenolpyruvate (Boehringer Mannheim, Germany) and [ring-2, 6)H] Phe (50 
Cilmmole, Moravek Biochemicals, Brea, CA).  Each reaction mixture had 3 Jlg pyruvate 
kinase (Boehringer Mannheim, Germany), 40 J1g tRNA
bu1k E.  coli (Boehringer 
Mannheim, Germany), 100 Jlg poly U (Boehringer Mannheim, Germany), 240 Jlg of  S-
150 enzymes, and 1.0 A260 unit of  50S subunits. 
The reaction was allowed to proceed for 45 minutes at 30°C.  100 J1l of  0.5 % Phe 
(SchwarziMann, Orangeburg, NY) was added to reduce background then 2 ml of 10 % 
(w/v) trichloroacetic acid (TCA) was added to precipitate the protein.  The mixture was 
incubated for 15 minutes at 90°C to deacylate the tRNA's and to reduce background.  The 
sample was filtered through a 13-mm Millipore GSWP 0.22-~  filter (Millipore Corp., 
Bedford, MA).  The filter was washed with 6 ml of  5 % TCA then again with 3 ml of  5 % 
TCA.  The filter was added to 5 ml of  Aquasol (Packard Instrument Company Inc., 
Meriden, CT) scintillation cocktail and counted in a Beckman scintillation counter 
(Beckman Instruments Inc., Fullerton, CA). 51 
3.3.  Filter-Binding Studies 
3.3.1  Preparation of  32P-Labeled 16S rRNA and Oligoribonucleotides 
To test whether the oligoribonucleotides had a lower affinity to 30S proteins in 
the reconstitution than the 16S rRNA to the 30S proteins, filter-binding assays were 
employed.  One picomole of  dephosphorylated 16S rRNA, synthesized CTlO, and CTII 
were 5' end-labeled with y[32p] ATP (6000 Cilmmol, New England Nuclear, Boston, 
MA) and T4 polynucleotide kinase (Sigma, St. Louis, MS).  The labeled RNA's were 
separated from freeye
2p] ATP by using Centricon-3 filters (Amicon, Beverly, MA). 
3.3.2  Filter-Binding Assays 
Filter-binding assays were performed similar to Draper et al. (1988).  To carry out 
a filter-binding titration, the RNA is renatured separately, incubated at 40°C for 15 
minutes in buffer 6.  Samples with protein at concentrations from zero to 2.0 ~  were 
incubated with RNA at a total concentration of  approximately 170 pM.  The total reaction 
volume was 50 III and the mixture was incubated for 15 minutes at 4°C in pre-siliconized 
centrifuge tubes (Intermountain Scientific Corp., Kaysville, UT).  The reaction mixture 
was then filtered through a Millipore 13-mm GSWP 0.22-J..Lm filter (Millipore Corp., 
MA) pre-wetted with buffer 6 and filtered under gentle suction.  The filters were then 
placed in 5 ml of  Aquasol scintillation cocktail (Packard Instruments, Meriden, CT) and 
counted in a Beckman LS 6000SC scintillation counter (Beckman Instruments Inc., 
Fullerton, CA). 52 
Chapter 4 
Results 
4.1  Growth Curve Studies and Northern Blot Analysis 
4.1.1.  Growth Curve Studies 
The PBSS842-2 phagemid was constructed by inserting a short DNA sequence 
into the PBS+ phagemid.  Sequence analysis confirmed the presence and correct 
sequence of  the insert within the PBSS842-2 phagemid (Figure 4.1).  The LlPBSS842-2 
phagemid was constructed, through PCR, by deleting the ribosomal binding site within 
the lacZ gene of  the PBSS842-2 phagemid. Sequence analysis also confirmed the correct 
deletion and correct insert sequence of  the LlPBSS842-2 phagemid.  Upon sequencing of 
the PBSS842-1 phagemid, the putative tandem triple insert sequence, it was found the 
sequence insert was not a full tandem triple insert sequence but in fact a conglomeration 
of several partial sequence inserts (data not shown).  The PBSS842-1  phagemid was not 
considered further. 
Sample growth curves of  E.  coli strain XL] -MRF' with PBSS842-2, LlPBSS842-2 
and PBS+ control phagemid grown in LB medium at 37°C are shown in Figure 4.2.  The 
growth curves are representative of  growth experiments with the above phagemids using 
different growth conditions.  The doubling times for these experiments, in the presence of 
IPTG and their no-IPTG control are shown in Table 4.1.  There is no or little increase in 
doubling time upon induction with IPTG of  the phagemids used in these experiments. 
1~',  coli strain XL I-MRF' was used in these experiments because this strain is the 
host strain for the PBS+ phagemid.  Strain XLI-MRF' is lacf1, so the Lac repressor is 53 
Figure 4.1.  Sequence of  the lacZ gene of  the PBSS842-2 phagemid.  The sequence starts 
at zero at the lacZ transcriptional start point.  The S8 binding site insert and the 
~BSS842-2  deletion are bold.  Boxes surround the sequences of  the S8 probe and lacZ 
probe. 54 
5' .. AA.TTGTCAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGCCAAGCTCGAAATTA 
3' ... TTAACAGTCGCCTATTGTTAAAGTGTGTCCTTTGTCGATACTGGTACTAATGCGGTTCGAGCTTTAAT 
~PBSS842-2  Deletion 
ACCCTCACTAAAGGGAACAAAAGCTTTGTTAAGTCAGATGTGAAAGAACTGCATCTGATACTGGCAACTGC 
TGGGAGTGATTTCCCTTGTTTTCG~CAATTCAGTCTACACTTTCTTGACGTAGACTATGACCGT~GACG 
S8 Binding Site Insert 
S8 Probe (boxed) 
AGGTCGACTCTAGAGGATCCGCGGGTACCGAGCTCGAATTCGCCCTATAGTGAGTCGTATTACAATTCACT 
TCCAGCTGAGATCTCCTAGGGGCCCATGGCTCGAGCTTAAGCGGGATATCACTC~GCATAATGTTAAGTG~ 
GGCCGTCGTTTTAC. .. 3 ' 
ICCGGCAGCAAAATGJ .. ·5 ' 
Figure 4.1 
LacZ Probe 55 
Figure 4.2.  Growth curve analysis of  }.'.  coli XL1-MRF'.  50-ml cultures were grown at 
37°C in LB medium with a 1.0-ml inoculation of  overnight culture.  IPTG was added at 
the start of  the analysis.  A.  Cells containing the PBSS842-2 phagemid.  B.  Cells 
containing the ~PBSS842-2  phagemid.  C.  Cells containing the PBS+ control phagemid. E 
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58 Table 4.1.  Doubling times of  cultures used in growth experiments. 
Doubling Time 
Temperature  Doubling Time  with IPTG 
Phagemid  Cell Line  Medium  (OC)  no IPTG (Hour)  (Hour) 
PBSS842-1  XL1-MRF'  LB  37  0.64  0.64 
PBSS842-1  XL1-MRF'  LB  37  0.62  0.62 
PBSS842-2  XL1-MRF'  LB  37  0.79  0.79 
PBSS842-2  XLI-MRF'  LB  37  0.83  0.83 
PBS+  XL1-MRF'  LB  37  0.74  0.74 
PBS+  XL1-MRF'  LB  37  0.74  0.76 
LWBSS842-2  XL1-MRF'  LB  37  0.73  0.70 
LWBSS842-2  XLI-MRF'  LB  37  0.73  0.74 
LWBSS842-2  XL1-MRF'  M9  24  3.9  3.9 
PBSS842-2  XL1-MRF'  M9  24  4.4  4.4 
LWBSS842-2  XLI-MRF'  M9  24  3.3  3.3 
LWBSS842-2  DH5a  M9  24  2.8  2.8 
PBSS842-2  DH5a  M9  24  3.3  3.3 
LWBSS842-2  DH5a  M9  24  3.3  3.3 
LWBSS842-2  DH5a  M9  24  3.5  37 
LWBSS842-2*  DH5a  M9  24  3.5  3.7 
LWBSS842-2*  DH5a  M9  24  3.7  3.7 
PBSS842-2  DH5a  M9  24  25  2.5 
PBSS842-2*  DH5a  M9  24  2  2.5 
PBSS842-2*  DH5a  M9  24  2.5  2.5 
*  IPTG added at 0.4 1\;00 units. 60 
expressed in high amounts.  E.  coli strain DHSa was also transformed with PBSS842-2, 
~PBSS842-2  and PBS+ phagemids and tested in the presence and absence of  the inducer 
IPIG.  DHSa expresses the Lac repressor in normal amounts and may have shown an 
increase in RNA production and in doubling time upon induction of  the phagemids with 
IPIG.  Strain DHSa transformed with the PBSS842-2 and  ~PBSS842-2  phagemids also 
produced no or little increase in doubling time when grown in the presence of  the inducer 
IPIG. 
4.1.2.  Northern Blot Analysis 
Northern blot analysis was used to monitor mRNA levels from the lacZ gene of 
the LlPBSS842-2, PBSS842-2, and PBS+ phagemid in response to induction with IPIG. 
LacZ mRNA in response to induction with IPIG along with the non-induced controls 
using the S8 probe is shown in Figure 4.3.  Ihe S8 probe is complementary to the S8 
binding site of  the 16S rRNA and the S8 binding site insert in the ~PBSS842-2  and 
PBSS842-2 phagemids.  16S rRNA is a positive control band for all the lanes when using 
the S8 probe and is seen in each lane. No insert mRNA was demonstrated in the non-
induced controls for all the cell lines within exposure time for the experiment (lanes 2, 4, 
6,8). Ihe XLI-MRF' with the PBS+ phagemid and the XLI-MRF' with no phagemid 
are both negative controls for the insert mRNA when induced with IPIG.  No message is 
seen below the 16S rRNA when induced with IPIG (lanes 5 and 7).  A small amount of 
message is seen below the 16S rRNA in lane 3 (Figure 4.3 B) corresponding to the 
PBSS842-2 phagemid, with the S8 binding site insert, induced with IPIG.  No message 
corresponding to the insert in the ~BSS842-2  induced with IPIG was demonstrated 
(lane I). 61 
Figure 4.3.  Northern blot analysis ofE. coli XLI-MRF' using the SS probe.  Lanes 1 and 
2 are LWBSSS42-2 induced with and without IPTG respectively.  Lanes 3 and 4 are 
PBSSS42-2 induced with and without IPTG respectively.  Lanes 5 and 6 are PBS+ 
control induced with and without IPTG respectively.  Lanes 7 and S are control cells with 
no phagemid with and without IPTG respectively.  A.  Blot exposed for 3 hours.  B.  Blot 
exposed for 6 hours. 62 
A 
B 
Figure 4.3 63 
LacZ mRNA levels in response to induction with IPTG using the lacZ probe are 
shown in Figure 44.  The lacZ probe is complementary to the phagemid lacZ mRNA 3' 
of  the insert and includes part of  the multiple cloning sequence.  No message was 
demonstrated in the non-induced controls for all cell lines (lanes 2, 4, 6, 8).  No message 
corresponding to the i1PBSS842-2IacZ mRNA was demonstrated (lane 1).  LacZ mRNA 
corresponding to the PBSS842-2 and the positive control for the lacZ probe, the PBS+ 
phagemid, in response to induction with IPTG was demonstrated in lanes 3 and 5 
respectively. 
4.2  Reconstitution Studies 
30S subunits can be reconstituted in vitro from purified 16S rRNA and TP30 (Traub 
and Nomura, 1969).  These reconstituted particles are found to be almost identical to 
isolated 30S particles in physical properties as well as functional properties, including 
poly V-directed polyphenylalanine synthesis.  Omission of S8 from the mixture results in 
particles that show an 87-98 % reduction in Phe incorporation.  This severe reduction of 
function was used to test the hypothesis since binding the oligoribonucleotide to S8 was 
expected to accomplish a similar effect.  In vitro reconstitutions were performed in the 
presence of  three unmodified oligoribonucleotides (CTI0, CTll, and the control CT4). 
CT  4 is a single-strand control oligoribonucleotide that had been shown previously not to 
bind protein S8 (Mougel et aI., 1993).  CTI0 and CTII are similar in sequence to the S8 
binding site on the 16S rRNA.  After reconstitution, the particles were assayed for 
function.  None of  the oligoribonucleotides showed a reduction of  function when added at 
up to a 10: 1 ratio of  the oligoribonucleotide to TP30 (Figure 4.5).  The negative control, 
CT4, was assayed to a 20: 1 ratio of  oligoribonucleotide to TP30 and showed no reduction 64 
Figure 4.4.  Northern blot analysis of  E.  coli XLI-MRF' using the lacZ probe.  The lanes 
are the same as those in Figure 4.3. 65 
Figure 4.4 66 
Figure 4.5.  Polyphenylalanine synthesis functional assay of 30S ribosomal subunits 
reconstituted in the presence ofoligoribonucleotides.  0.5  AZ60 units of30S subunits were 
tested in triplicate for each ratio of  oligoribonucleotide: protein.  Columns represent the 
average of  two experiments and the error bars represent the high and low of  the 
experiments.  A.  Reconstitution in the presence ofCT4.  B.  Reconstitution in the 
presence ofCTlO.  C.  Reconstitution in the presence ofCTll. 67 
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Figure 4.5 cou't of  function at that level (Figure 4.5A).  CTll was also assayed to a 20: 1 ratio of 
oligoribonucleotide to TP30 and showed a 20 % decrease of function at that ratio (one-
sided p-value < 0.0005; t-test) (Figure 4.5 C). 
4.3  Filter Binding Studies 
70 
Filter-binding assays were performed to test whether the oligoribonucleotides were 
binding to a protein in the TP30 mixture (Figure 4.6).  Equal amounts of  RNA were 
incubated with increasing amounts ofTP30 then filtered under gentle suction.  The non-
specific retention of  radioactivity on the filters averaged 15 % for the 
oligoribonucleotides and 26 % for the 16S RNA.  For each experiment, non-specific 
bound radioactivity was corrected for.  The yield of  retention of  the complex on the filter 
averaged 55 %.  The oligoribonucleotides CTI0 and CTl1 reach the similar percent 
retentions at much higher protein concentrations than the 16S rRNA, signifying a lower 
affinity for the oligoribonucleotides to the proteins than the 16S rRNA to the proteins. 
The estimated K! for both oligoribonucleotides is approximately five times lower than the 
estimated Kd for the 16S RNA. Figure 4.6.  Filter binding comparisons ofoligoribonucleotides with 16S RNA. 
Approximately 170 picomoles Of
32p end-labeled RNA was incubated with increasing 
amounts of30S protein at 4°C then filtered under gentle suction.  A.  CTlO comparison 
with 16S RNA.  B.  CT11  comparison with 16S RNA. 
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Chapter 5 
Discussion 
5.1  Growth Experiments and Northern Blot Analysis 
A difficulty in using analog oligonucleotides as antibiotics is penetration of  the 
bacterial cell membrane.  A method to study the inhibition of  gene expression in bacteria 
has been to clone a sequence under an inducible promoter into bacteria.  This has been 
achieved for antisense inhibition of  gene expression (Parish and Stoker, 1997) and 
ribozyme inhibition of  gene expression (Sioud and Drlica, 1991; Inokuchi et al., 1994). 
This method of  delivery was utilized in this study. 
The PBSS842-2 and LlPBSS842-2 (the Shine-Dalgarno and AUG start site deleted) 
phagemids were constructed by inserting a short DNA sequence homologous to the 16S 
RNA binding site of  S8 under a lacZ promoter.  Upon induction with IPTG, RNA 
polymerase would synthesize a mRNA that should be able to fold into the proper 
structure to bind protein S8.  The binding of  protein S8 to the introduced RNA structure 
would inhibit the binding of  S8 to the 16S RNA.  This would cause protein S8 to be 
unavailable during ribosomal assembly and thus produce incomplete 30S subunits unable 
to translate.  When this mechanism is induced in the cell, the expectation would be an 
increase in generation time among the bacteria. 
Upon induction of  the various cell lines including PBS+ controls with IPTG, little or 
no change in growth was apparent (Table 4.1).  This lack of  growth inhibition occurred 
when using two different strains of  E.  coli grown at different temperatures and using 
different media. 75 
Northern blot analysis was performed to monitor mRNA levels from the lacZ gene 
and the insert ofthe PBSS842-2, ~PBSS842-2,  and the PBS+ phagemids upon induction 
with IPTG.  The S8 probe is complementary to the binding site of  the 16S RNA and the 
binding site insert in the PBSS842-2 and MBSS842-2 phagemids.  A small amount of 
message is seen below the 16S rRNA in lane 3 of  Figure 4.3 corresponding to the 
PBSS842-2 phagemid, with the S8 binding site induced with IPTG.  No message 
corresponding to the insert in the MBSS842-2 was demonstrated (lane 1 of  Figure 4.3). 
LacZ mRNA levels using the lacZ probe are shown in Figure 4.4.  The lacZ probe 
is complementary to the phagemid lacZ mRNA and includes part of  the part of  the 
multiple cloning sequence.  LacZ mRNA corresponding to the PBSS842-2 and the 
positive control, the PBS+ phagemid, in response to induction with IPTG, is 
demonstrated in lanes 3 and 5 in Figure 4.4 respectively.  The levels of  mRNA appear to 
be similar in both the control and insert phagemid.  No message was demonstrated 
corresponding to the MBSS842-2 message. 
Northern blot analysis demonstrates there is message coming from the insert of 
the PBSS842-2 phagemid and it is similar to the S8 binding site on the 16S RNA.  The 
amount of  message is much less than the amount of 16S RNA in the cell.  The small 
amount is not due to endonucleolytic attack due to S8 binding the insert since the PBS+ 
control does not have the insert and its lacZ message is a similar level. 
The MBSS842-2 phagemid was constructed so translating ribosomes could not 
bind to the message and inhibit folding of  the insert binding site or inhibit the binding of 
S8 to the site.  No message from the phagemid was demonstrated under the conditions of 
the experiment using either of  the probes.  One reason for this could be due to a mutation 76 
in the leader region of  the iacZ gene during the PCR reaction.  Sequencing of  the gene 
revealed a T  ~C  mutation at position -36. This position in the AT-rich -35 region 
would produce a down mutation.  One would still expect to see some message produced. 
Other possibilities include a decrease in half-life ofthe message due to removal of  the 
Shine-Dalgamo and translational start site from the message as well as endonucleolytic 
cleavage 3' of  the bound protein S8 if  S8 is indeed bound to the site on the mRNA.  S8 
has been shown to regulate the synthesis of  the first and second gene products of  the spc 
operon (L14 and L24) by binding at the mRNA target site (similar to the S8 binding site 
on the 16S RNA) and inducing endonucleolytic mRNA degradation (Mattheakis et ai., 
1989).  These data together may account for the lack of  message from the MlBSS842-2 
phagemid upon induction with IPTG within the time course of  the experiment. 
5.2  Reconstitution Studies and Filter-Binding Analysis 
In vitro reconstitution assays were employed to test whether the binding of 
oligoribonucleotides of  similar sequence to ribosomal protein binding sites on the 16S 
RNA could inhibit ribosomal assembly.  Since the protein S8 can no longer bind to the 
16S RNA, non-functional particles would result and could be assayed for 
polyphenylalanine synthesis.  The oligoribonucleotides CTlO and CTII are similar to the 
protein S8 binding site on the 16S RNA.  The sequence ofthe core nucleotides in CTll 
was chosen because it showed the same affinity as the homologous or wild type site in 
SELEX experiments (Moine et ai., 1997).  CT4 is a single strand control 
oligoribonucleotide similar in sequence to half of  the S8 binding site that had been shown 
previously not to bind to protein S8 (Mougel et ai., 1993). 77 
CT4 was assayed at up to a 20: 1 ratio of  oligoribonucleotide to TP30 and showed no 
reduction of  function up to that level.  CT  1  0 was increased only up to a 10: 1 ratio of 
oligoribonucleotide to TP30 and showed no inhibition of  function.  CTII was assayed up 
to a 20: 1 ratio of  oligoribonucleotide to TP30 and it showed a 20 % reduction of 
polyphenylalanine synthesis at that level (one-sided p-value < 0.0005; t-test). 
This result was unexpectedly high and filter-binding assays were employed to test 
whether the oligoribonucleotides could bind a protein in TP30.  It was determined that 
CTII and CTIO could both bind TP30 but at a lower affmity than the 16S RNA. 
5.3 Analog Oligonucleotides as Antibiotics 
There have been few reported efforts to use oligonucleotide analogs in bacterial 
systems (Jayaraman et al., 1981; Miller et al., 1981; Rahman et al., 1991; Chrisey et al., 
1993; Rapaport et al., 1996; Good and Nielson, 1998).  Oligonucleotide targets have been 
mRNA, through an antisense mechanism and the anti-Shine-Dalgarno sequence on the 
16S RNA. 
One hurdle for use of  analog oligonucleotides as antibiotics is bacterial cell 
membrane penetration.  Good and Nielsen (1998) found that wild type E.  coli were 
hardly affected by peptide nucleic acids (PNAs).  A permeable strain of  E.  coli could be 
inhibited at micromolar levels of  antisense PNAs suggesting cell uptake ofPNAs is 
limited.  Rapaport et al. (1996) studying the antimycobacterial activities of  antisense 
phosphorothioates had to use ethambutol (which induces alterations in the cell wall) and 
covalently attached either biotin or D-cycloserine to the oligonucleotides to produce 
growth inhibition in Mycobacterium smegmatis.  Rahman et al. (1991) used polyethyleneglycol (molecular weight 1000) (PEG-1000) attached to methyl carbamate 
DNAs of  three or four nucleotides in length to inhibit translation in E.  coli D-1 0 cells. 
They also used a cell-wall-Iess strain of  E.  coli to elicit an effect. 
78 
Chrisey et al. (1993) studied the internalization of  phosphorothioates by Vibrio 
parahaemolyticus by cell fractionation techniques without attempting to permeabilize the 
cells.  The phosphorothioate was found primarily in the periplasm and peptidoglycan 
layer.  There was also a significant amount recovered from the cytosol (up to 1 %) and 
more so when minimal medium was used, possibly because the bacteria maybe less 
discriminating when subjected to a starved environment or proteins in the rich media may 
bind the oligonucleotides making the oligonucleotides unavailable for uptake to the 
bacteria.  Taken together, it is possible that advances in chemical modification of  analog 
oligonucleotides could increase bacterial cell penetration.  Chemical modifications have 
resulted in increased stability and uptake in eukaryotic systems and similar success 
should be possible for delivery into bacteria. 
5.4 Other Antibiotics that Target Ribosome Assembly 
There are antibiotics that inhibit ribosomal assembly suggesting that ribosomal 
assembly is an effective target for antibiotics.  Chloramphenicol is one such antibiotic 
(Osawa et al., 1969).  Its cellular target is the binding to the 50S subunit and its action 
affects the orientation of  aminoacyl-tRNA in a way that prevents peptide bond formation. 
It slows or stops protein synthesis without affecting DNA or RNA synthesis.  It also 
inhibits ribosomal subunit synthesis through the breakdown of  cooperative assembly 
under high rRNA to r-protein ratios (Dodd and Nomura, 1991).  Growth inhibition by chloramphenicol results in incomplete assembly of  both ribosomal subunits that is a 
generalized effect on the translation of  mRNA's for all ribosomal proteins. 
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Other antibiotics that affect ribosomal assembly are erythromycin and other 
macrolides, including the second-generation macrolides, the ketolides (Chittum and 
Champney, 1995; Champney and Burdine, 1995; Champney and Tober, 1998).  The 
exact mechanism of  protein synthesis inhibition by the macrolides is not well understood; 
they may inhibit a step in translation between initiation and elongation or affect Psite-
dependent binding or dissociation of  peptidyl tRNA.  The molar concentration of 
erythromycin required to affect translation in vitro is significantly greater than the 
measured inhibitory concentrations in vivo, suggesting a second target in cells (Corcoran, 
1984).  Studies using different macrolides and ketolides in Staphylococcus aureus 
suggest that there may be related binding sites for macrolide-like compounds, one that 
affects translational activity, and another on a precursor large subunit particle which leads 
to assembly inhibition.  50S subunit formation is specifically inhibited.  The breakdown 
of  mature 50S subunits is not affected and 30S assembly is not inhibited (Chittum and 
Champney, 1995).  Not all macrolide-like compounds are effective 50S assembly 
inhibitors potentially due to side groups on the molecules but the additional effect on 
ribosome assembly may be an important target for drug activity. 
5.5  Summary 
This thesis project was designed to explore the feasibility of  using analog 
oligoribonucleotides targeting 30S ribosomal subunit assembly as possible antibiotics. 
The initial approach attempted to bypass the cell's lack of  permeability to 80 
oligonucleotides by cloning the site into a vector and transforming it into cells.  The lack 
of  growth inhibition upon induction of  the phagemid to produce the binding site, and the 
difficulty in interpreting the events occurring in the cell leading to the lack of  inhibition, 
lead to the pursuit of  answering the question through an in vitro system. 
The aim of  the in vitro set of  experiments was to initially bind unmodified 
oligoribonucleotides to TP30 in an in vitro reconstitution system and test the disruption 
of  assembly through the inhibition of  function in the polyphenylalanine synthesis assay. 
If  an oligoribonucleotide tested positive, that is, the inhibition of  ribosome function at 
low concentrations, then a modified oligoribonucleotide of  the same sequence would 
have been tested similarly in vitro. 
One of  the oligoribonucleotides tested (CTll) was found to inhibit function but only 
at high concentrations.  This lead to the test of  whether the oligoribonucleotides were in 
fact binding protein in the reconstitution mixture.  It was determined that the 
oligoribonucleotides were indeed binding protein in the mixture but with a lower affinity 
than the proteins bind to 16S RNA.  16S RNA is a very abundant molecule in the cell. 
Under optimal growth conditions, 16S RNA is rapidly produced from the seven rRNA 
operons.  This leads to the overall conclusion that this set of  oligoribonucleotides tested 
can bind TP30 and inhibit ribosome assembly but at concentrations that would be too 
great to be clinically useful. I·· -
I 
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